We are live on ! Find out more
DNTH icon

Dianthus Therapeutics
DNTH

92 hedge funds and large institutions have $255M invested in Dianthus Therapeutics in 2020 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 35 increasing their positions, 25 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 25

17% more capital invested

Capital invested by funds: $217M → $255M (+$37.9M)

0.07% more ownership

Funds ownership: 4.14% → 4.21% (+0.07%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

2% less funds holding

Funds holding: 94 → 92 (-2)

13% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 8

72% less call options, than puts

Call options by funds: $46K | Put options by funds: $164K

Holders
92
Holders Change
-2
Holders Change %
-2.13%
% of All Funds
1.63%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
7
Increased
35
Reduced
25
Closed
8
Calls
$46K
Puts
$164K
Net Calls
-$118K
Net Calls Change
-$32K

Top Buyers

1
ACM
Aquilo Capital Management
California
+$9.27M
2
JP Morgan Chase
JP Morgan Chase
New York
+$1.51M
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$1.13M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$960K
5
PIM
Platinum Investment Management
Australia
+$834K

Top Sellers

1
EAM
Eventide Asset Management
Massachusetts
-$9.63M
2
Renaissance Technologies
Renaissance Technologies
New York
-$1.05M
3
PM
Prosight Management
Texas
-$840K
4
Squarepoint
Squarepoint
New York
-$376K
5
UBS AM
UBS AM
Illinois
-$368K
Name Holding Trade Value Shares
Change 		Change in
Stake
AQR Capital Management
51
AQR Capital Management
Connecticut
$205K -$16.8K -148 -8%
Cerity Partners
52
Cerity Partners
New York
$204K – – –
RhumbLine Advisers
53
RhumbLine Advisers
Massachusetts
$199K +$38K +335 +27%
OC
54
Oppenheimer & Co
New York
$157K – – –
AWM
55
Aries Wealth Management
Maine
$152K +$42.5K +375 +50%
Wells Fargo
56
Wells Fargo
California
$143K +$44.7K +394 +53%
EW
57
Evoke Wealth
California
$142K – – –
Bank of America
58
Bank of America
North Carolina
$131K -$194K -1,714 -62%
Deutsche Bank
59
Deutsche Bank
Germany
$125K +$31K +273 +38%
BFM
60
Boothbay Fund Management
New York
$123K +$111K +978 New
Manulife (Manufacturers Life Insurance)
61
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$118K +$17.7K +156 +20%
Susquehanna International Group
62
Susquehanna International Group
Pennsylvania
$114K -$32.8K -289 -24%
CSS
63
Cubist Systematic Strategies
Connecticut
$112K +$3.4K +30 +3%
Squarepoint
64
Squarepoint
New York
$110K -$376K -3,313 -79%
ProShare Advisors
65
ProShare Advisors
Maryland
$94K +$12.4K +109 +17%
New York State Common Retirement Fund
66
New York State Common Retirement Fund
New York
$91K +$46K +406 +128%
State Board of Administration of Florida Retirement System
67
State Board of Administration of Florida Retirement System
Florida
$80K – – –
VOYA Investment Management
68
VOYA Investment Management
Georgia
$79K +$71.4K +630 New
Citigroup
69
Citigroup
New York
$52K +$11K +97 +31%
WC
70
Wexford Capital
Florida
$44K +$39.9K +352 New
Federated Hermes
71
Federated Hermes
Pennsylvania
$37K +$2.95K +26 +10%
UBS Group
72
UBS Group
Switzerland
$33K +$30K +265 New
CAPTRUST Financial Advisors
73
CAPTRUST Financial Advisors
North Carolina
$31K – – –
BNP Paribas Financial Markets
74
BNP Paribas Financial Markets
France
$30K -$7.37K -65 -21%
Bank of Montreal
75
Bank of Montreal
Ontario, Canada
$28K +$16K +141 +235%
1 2
3
4

DNTH Hedge Fund Activity: Q4 2020 in Review

92 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Dianthus Therapeutics (DNTH) for Q4 2020, worth a combined $255M — up 17% from $217M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of DNTH and 7 opened new positions — a net loss of 1 holder — while 25 trimmed existing stakes and 35 added.

The largest buyer was Aquilo Capital Management, adding an estimated $9.27M. The largest seller was Eventide Asset Management, cutting an estimated $9.63M.

  • 92 institutional investors held Dianthus Therapeutics (DNTH) as of Q4 2020, down from 94 in Q3 2020.
  • Funds reported $255M of Dianthus Therapeutics stock for Q4 2020, up 17% quarter-over-quarter.
  • 7 funds opened new Dianthus Therapeutics positions in Q4 2020 and 8 closed out, a net change of -1 holder.
  • The largest Dianthus Therapeutics buyer in Q4 2020 was Aquilo Capital Management, an estimated $9.27M added.
  • The largest Dianthus Therapeutics seller in Q4 2020 was Eventide Asset Management, an estimated $9.63M sold.

Based on aggregated 13F filings for Q4 2020.